Dynamic interplay between RPL3- and RPL3L-containing ribosomes modulates mitochondrial activity in the mammalian heart
Ivan MilenkoviciD, Helaine Graziele Santos VieiraiD, Morghan C. LucasiD, Jorge Ruiz‐OreraiD, Giannino PatoneiD, Scott H. KesteveniD, Jianxin WuiD, Michael Patrick FeneleyiD, Guadalupe EspadasiD, Eduard SabidóiD, Norbert HübneriD, Sebastiaan van HeeschiD, Mirko VölkersiD, Eva Maria NovoaiD
Abstract
The existence of naturally occurring ribosome heterogeneity is now a well-acknowledged phenomenon. However, whether this heterogeneity leads to functionally diverse specialized ribosomes is still a controversial topic. Here, we explore the biological function of RPL3L (uL3L), a ribosomal protein (RP) paralog of RPL3 (uL3) that is exclusively expressed in muscle and heart tissues, by generating a viable homozygous Rpl3l knockout mouse strain. We identify a rescue mechanism in which, upon RPL3L depletion, RPL3 becomes upregulated, yielding RPL3-containing ribosomes instead of RPL3L-containing ribosomes that are typically found in cardiomyocytes. Using both ribosome profiling (Ribo-Seq) and a novel orthogonal approach consisting of ribosome pulldown coupled to nanopore sequencing (Nano-TRAP), we find that RPL3L neither modulates translational efficiency nor ribosome affinity towards a specific subset of transcripts. By contrast, we show that depletion of RPL3L leads to increased ribosome-mitochondria interactions in cardiomyocytes, which is accompanied by a significant increase in ATP levels, potentially as a result of mitochondrial activity fine-tuning. Our results demonstrate that the existence of tissue-specific RP paralogs does not necessarily lead to enhanced translation of specific transcripts or modulation of translational output. Instead, we reveal a complex cellular scenario in which RPL3L modulates the expression of RPL3, which in turn affects ribosomal subcellular localization and, ultimately, mitochondrial activity.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 54
- FWCI
- 4.79
- Field percentile
- top 3%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pathogenetic mechanisms of muscle-specific ribosomes in dilated cardiomyopathy
Michael Robert Murphy, Mythily Ganapathi, … Xuebing Wu·Nature Cardiovascular ResearchPeer-reviewed·Jan 6, 2026
- Ribosomal protein RPL39L is an efficiency factor in the cotranslational folding ofproteins with alpha helical domains
Arka Banerjee, Meriç Ataman, … Mihaela Zavolan·bioRxiv·Apr 3, 2023
- Cytosolic Ribosomal Protein Haploinsufficiency affects Mitochondrial Morphology and Respiration
Agustian Surya, Blythe Marie Bolton, … Elif Sarinay Cenik·bioRxiv·Apr 16, 2024
- Mutations in RPL3L and MYZAP increase risk of atrial fibrillation
Rósa B. Þórólfsdóttir, Garðar Sveinbjörnsson, … Kāri Stefánsson·bioRxiv·Nov 21, 2017
- eIF3 associates with 80S ribosomes to promote translation elongation, mitochondrial homeostasis, and muscle health
Y. Lin, F. Li, … D. A. Wolf·bioRxiv·Dec 22, 2019
- Ribosomal Protein SA (RPSA) is required for localized translation and sarcomere maintenance in mice